BioShares Biotechnology Clinical Trials ETF Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy Signal from Moving Average: Indicates potential upward movement.
Sell Signal (MA)
Sell Signal from Moving Average: Indicates potential downward movement.
AI Analysis of BBC
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
BioShares Biotechnology Clinical Trials ETF price ended at $27.66 on Friday, after gaining 1.43%
(Updated on Oct 04, 2024)
Hold candidate since Oct 02, 2024
Gain 0.48%
The BioShares Biotechnology Clinical Trials ETF price gained 1.43% on the last trading day (Friday, 4th Oct 2024), rising from $27.27 to $27.66. During the last trading day the ETF fluctuated 0.467% from a day low at $27.53 to a day high of $27.66. The price has fallen in 5 of the last 10 days and is down by -5.69% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 117 more shares were traded than the day before. In total, 543 shares were bought and sold for approximately $15.02 thousand.
The ETF is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect BioShares Biotechnology Clinical Trials ETF with a 90% probability to be traded between $26.23 and $30.99 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and ETF seldom manage to go directly from the bottom of a trend up to the top. ETF turning up in the middle of a horizontal trend are therefore considered to be potential runners.
BBC Signals & Forecast
There are mixed signals in the ETF today. The BioShares Biotechnology Clinical Trials ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance from the long-term Moving Average at $27.85. On a fall, the ETF will find some support from the short-term average at $27.59. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, September 19, 2024, and so far it has fallen -6.46%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). BioShares Biotechnology Clinical Trials has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for BioShares Biotechnology Clinical Trials ETF
On the downside, the ETF finds support just below today's level from accumulated volume at $26.09 and $25.39. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, BioShares Biotechnology Clinical Trials finds support just below today's level at $26.09. If this is broken, then the next support from accumulated volume will be at $25.39 and $24.75.
This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $0.129 between high and low, or 0.467%. For the last week, the ETF has had daily average volatility of 0.678%.
Our recommended stop-loss: $26.18 (-5.34%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 11 days ago.)
Trading Expectations (BBC) For The Upcoming Trading Day Of Monday 7th
For the upcoming trading day on Monday, 7th we expect BioShares Biotechnology Clinical Trials Fund to open at $27.62, and during the day (based on 14 day Average True Range), to move between $27.15 and $28.17, which gives a possible trading interval of +/-$0.511 (+/-1.85%) up or down from last closing price. If BioShares Biotechnology Clinical Trials Fund takes out the full calculated possible swing range there will be an estimated 3.70% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $27.79 (0.48%) than the support at $26.09 (5.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BioShares Biotechnology Clinical Trials Fund ETF A Buy?
BioShares Biotechnology Clinical Trials holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.563
Hold/Accumulate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 7, 2024 - $27.62 ( 0.155%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for BBC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 27.75 | 0.310% |
| R2 | 27.70 | 0.132% |
| R1 | 27.67 | 0.0226% |
| Price | 27.66 | |
| S1 | 27.57 | -0.333% |
| S2 | 27.54 | -0.442% |
| S3 | 27.49 | -0.620% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.11 | 5.24% |
| R2 | 28.33 | 2.42% |
| R1 | 27.79 | 0.477% |
| Price | 27.66 | |
| S1 | 26.09 | -5.69% |
| S2 | 25.39 | -8.21% |
| S3 | 24.75 | -10.53% |
BBC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 20, 2023 | Dec 20, 2023 | Dec 20, 2023 | $0.0820 | 0.369% |
| 2 | Dec 19, 2017 | Dec 20, 2017 | Dec 27, 2017 | $0.297 | 1.04% |
| 3 | Dec 21, 2015 | Dec 21, 2015 | Dec 29, 2015 | $0.147 | 0.498% |
FAQ
Click here for our free guide on how to buy BioShares Biotechnology Clinical Trials Fund ETF.
